Fuwai Hospital
中国医学科学院阜外心血管病医院
Listed for 6 of the 53 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.
Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.
No official website checked for this hospital yet.
Research at Fuwai Hospital
Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.
Only the 53 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed
- Osteosarcoma骨肉瘤1 paper led
- Neuroblastoma神经母细胞瘤1 paper led
- Haemophilia A血友病 A1 paper led
- Takayasu arteritis大动脉炎14 papers led
- Fabry disease法布雷病2 papers led1 open trial led
- Behçet disease白塞病5 papers led
Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Hepatoblastoma, Retinoblastoma, Chordoma, Gastrointestinal stromal tumour, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Beta thalassaemia, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Anti-NMDA receptor encephalitis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Pompe disease, Duchenne muscular dystrophy, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.
Cancer
Osteosarcoma
骨肉瘤Led 1 of the 2,257 English-language PubMed papers on osteosarcoma with an author in mainland China, 2021–2025: 0.04%.
- Trials led
- 0
- any status, ClinicalTrials.gov
- Open trials led
- 0
- recruiting or about to
- Open trials as a site
- 0
- led by another institution
37 hospitals in Beijing for osteosarcoma570 hospitals in China for osteosarcoma
No open trial on osteosarcoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.
The records behind these numbers
Hospital name read automatically from author addresses, not yet checked by hand.
Cancer
Neuroblastoma
神经母细胞瘤Led 1 of the 1,132 English-language PubMed papers on neuroblastoma with an author in mainland China, 2021–2025: 0.09%.
- Trials led
- 0
- any status, ClinicalTrials.gov
- Open trials led
- 0
- recruiting or about to
- Open trials as a site
- 0
- led by another institution
23 hospitals in Beijing for neuroblastoma321 hospitals in China for neuroblastoma
No open trial on neuroblastoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.
The records behind these numbers
Hospital name read automatically from author addresses, not yet checked by hand.
Blood disorders
Haemophilia A
血友病 ALed 1 of the 272 English-language PubMed papers on haemophilia A with an author in mainland China, 2021–2025: 0.4%.
- Trials led
- 0
- any status, ClinicalTrials.gov
- Open trials led
- 0
- recruiting or about to
- Open trials as a site
- 0
- led by another institution
14 hospitals in Beijing for haemophilia A132 hospitals in China for haemophilia A
No open trial on haemophilia A lists this hospital on ClinicalTrials.gov on 13 Nov 2026.
The records behind these numbers
Hospital name read automatically from author addresses, not yet checked by hand.
Other diseases
Takayasu arteritis
大动脉炎Led 14 of the 187 English-language PubMed papers on Takayasu arteritis with an author in mainland China, 2021–2025: 7.5%.
- Open trials led
- 0
- recruiting or about to
24 hospitals in Beijing for Takayasu arteritis100 hospitals in China for Takayasu arteritis
Open trials with this hospital 1
Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 13 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.
- RecruitingTreatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement
- Phase
- Not given
- Started
- 2014-01
- Registry
- NCT05388682
Age not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
The records behind these numbers
Hospital name read automatically from author addresses, not yet checked by hand.
Papers it led14
- Endovascular Therapy for Supra-aortic Artery Stenosis Caused by Takayasu's Arteritis: Long Term Results.
- Assessment of Coronary Involvement with MDCT and Long-term Outcomes in Patients with Takayasu's Arteritis.
- Alterations of Gut Microbiome, Metabolome, and Lipidome in Takayasu Arteritis.
- Comparison of long-term survival after endovascular treatment versus medical therapy in patients with Takayasu's arteritis and pulmonary artery stenosis.
- Angiographic classification of pulmonary vascular lesion in Takayasu arteritis: A cohort study.
- A single-center cohort of mid-aortic syndrome among adults in China: Etiology, presentation and imaging features.
- Patient With Takayasu Arteritis Treated with the Ozaki Procedure and Ascending Aorta Replacement.
- Characteristics of four-limb blood pressure and brachial-ankle pulse wave velocity in Chinese patients with Takayasu arteritis.
- Long-term outcomes and prognostic predictors of patients with Takayasu's arteritis along with pulmonary artery involvement.
- Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty in Patients With Takayasu Arteritis and Pulmonary Hypertension.
- Clinical Scenario and Long-Term Outcome of Childhood Takayasu Arteritis Undergoing 121 Endovascular Interventions: A Large Cohort Over a Fifteen-Year Period.
- 18F-FDG PET/CT plays a unique role in the management of Takayasu arteritis patients with atypical manifestations.
- Elevated chemokines concentration is associated with disease activity in Takayasu arteritis.
- Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients.
Chinese-language papers (not in the count)1
Earlier papers (2016–2020)27
- Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis.
- Surgical Treatment in Patients With Aortic Regurgitation Due to Takayasu Arteritis.
- Pulmonary Artery Involvement in Patients with Takayasu Arteritis.
- Clinical Course, Management, and Outcomes of Pediatric Takayasu Arteritis Initially Presenting With Hypertension: A 16-year overview.
- Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients.
- Novel Biomarkers for the Precisive Diagnosis and Activity Classification of Takayasu Arteritis.
- Association between increased arterial stiffness measured by brachial-ankle pulse wave velocity and cardiovascular events in patients with Takayasu's arteritis.
- Association of interleukin-6 and interleukin-10 expression, gene polymorphisms, and Takayasu arteritis in a Chinese Han population.
- Assessment of disease activity in Takayasu arteritis: A quantitative study with computed tomography angiography.
- Endovascular Treatment of Iliac Artery Stenosis Caused by Takayasu Arteritis: A 10-Year Experience.
- [Clinical experience in the diagnosis and treatment of aortic stenosis caused by Takayasu arteritis in pediatric patients].
- Stenting for middle aortic syndrome caused by Takayasu arteritis-immediate and long-term outcomes.
- The presentation and management of hypertension in a large cohort of Takayasu arteritis.
- Time trends regarding the etiology of renal artery stenosis: 18 years' experience from the China Center for Cardiovascular Disease.
- Cardiac Valve Involvement in Takayasu Arteritis Is Common: A Retrospective Study of 1,069 Patients Over 25 Years.
- An unrecognised presentation of Takayasu arteritis: superficial femoral artery involvement.
- Outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with Takayasu arteritis.
- Long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention for Takayasu arteritis patients with coronary artery involvement.
- Aortic Aneurysm in Takayasu Arteritis.
- Aortic Dissection in Takayasu Arteritis.
- Anaemia and low body mass index are associated with increased cardiovascular disease in patients with Takayasu arteritis.
- High-sensitivity C-reactive protein predicts adverse cardiovascular events in patients with Takayasu arteritis with coronary artery involvement.
- Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis.
- Lack of association between polymorphisms in interleukin (IL)-12, IL-12R, IL-23, IL-23R genes and Takayasu arteritis in a Chinese population.
- Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results.
- Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China.
- [Clinical features of Takayasu arteritis patients with pulmonary hypertension due to pulmonary artery involvement].
All its trials on ClinicalTrials.gov, any status2
Other diseases
Fabry disease
法布雷病Led 2 of the 73 English-language PubMed papers on Fabry disease with an author in mainland China, 2021–2025: 2.7%.
9 hospitals in Beijing for Fabry disease80 hospitals in China for Fabry disease
Open trials with this hospital 2
Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 13 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.
- RecruitingPrecision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
- Phase
- Not given
- Started
- 2010-01
- Registry
- NCT07336394
Age not stated (registered criteria)
Led by Fuwai HospitalBeijing
- RecruitingCVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study
- Phase
- Not given
- Started
- 2024-12
- Registry
- NCT06512571
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
The records behind these numbers
Hospital name read automatically from author addresses, not yet checked by hand.
Papers it led2
Other diseases
Behçet disease
白塞病Led 5 of the 245 English-language PubMed papers on Behçet disease with an author in mainland China, 2021–2025: 2.0%.
- Trials led
- 0
- any status, ClinicalTrials.gov
- Open trials led
- 0
- recruiting or about to
- Open trials as a site
- 0
- led by another institution
19 hospitals in Beijing for Behçet disease139 hospitals in China for Behçet disease
No open trial on Behçet disease lists this hospital on ClinicalTrials.gov on 13 Nov 2026.
The records behind these numbers
Hospital name read automatically from author addresses, not yet checked by hand.
Papers it led5
- Paediatric aortic regurgitation secondary to Behçet's disease: aortic cusp replacement with autologous pericardium.
- Imaging characteristics and prognostic factors of Behcet's disease with arterial involvement: A long-term follow-up study.
- Alterations of Gut Microbiome, Metabolome, and Lipidome in Takayasu Arteritis.
- A single-center cohort of mid-aortic syndrome among adults in China: Etiology, presentation and imaging features.
- Flanged Bentall Plus Cabrol Procedure for Interventricular Septal Dissection in Behçet's Disease.
Getting in touch
Name card to show staff or a driver
中国医学科学院阜外心血管病医院
Fuwai Hospital
北京
Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.
Inquiry letter in English and Chinese
Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.
Records hospitals usually ask for
- A recent summary or letter from the treating doctor
- Pathology report
- Scans (CT, MRI, PET) with their reports, and the images if possible
- Treatments so far, with dates
- Current medicines
What to do next
Where these numbers come from
Papers
English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions
Trials
ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.
Identifiers and other names
No hospital-level ROR record matched.